ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse

TELMISARTANUM

Active substance (INN) · ATC C09DA07 · 30 products authorised in Romania
◀ Back
1

Protocols it appears in

As a medicine of the protocol (in the title) or only mentioned in the text

CodeProtocolStatusRoleSublistGP
M09AX03 ATALUREN In force mentioned in the text C2- P6.21 NO
2

Authorised brand products (ANMDM)

The Romanian register of medicines for human use, updated daily

Brand nameFormStrengthHolderATCRx
ACTELSAR HCT 40 mg/12,5 mgCOMPR.40mg/12,5mgACTAVIS GROUP PTC EHF - ISLANDAC09DA07PRF
ACTELSAR HCT 80 mg/12,5 mgCOMPR.80mg/12,5mgACTAVIS GROUP PTC EHF. - ISLANDAC09DA07PRF
ACTELSAR HCT 80 mg/25mgCOMPR.80mg/25mgACTAVIS GROUP PTC EHF. - ISLANDAC09DA07PRF
MICARDIS 80 mgCOMPR.80mgBOEHRINGER INGELHEIM INT. GMBH - GERMANIAC09CA07P-6L
MICARDISPLUS 40/12,5mgCOMPR.40/12,5mgBOEHRINGER INGELHEIM INT. GMBH - GERMANIAC09DA07P-6L
MICARDISPLUS 80/12,5mgCOMPR.80/12,5mgBOEHRINGER INGELHEIM INT. GMBH - GERMANIAC09DA07P-6L
MICARDISPLUS 80/25mgCOMPR.80/25mgBOEHRINGER INGELHEIM INTERNATIONAL GMBH - GERMANIAC09DA07P-6L
TELASSMO 40 mg/10 mgCOMPR.40mg/10mgKRKA, D.D., NOVO MESTO - SLOVENIAC09DB04PRF
TELASSMO 40 mg/5 mgCOMPR.40mg/5mgKRKA, D.D., NOVO MESTO - SLOVENIAC09DB04PRF
TELASSMO 80 mg/10 mgCOMPR.80mg/10mgKRKA, D.D., NOVO MESTO - SLOVENIAC09DB04PRF
TELASSMO 80 mg/5 mgCOMPR.80mg/5mgKRKA, D.D., NOVO MESTO - SLOVENIAC09DB04PRF
TELMISARTAN ACTAVIS 40mgCOMPR.40 mgACTAVIS GROUP PTC EHF - ISLANDAC09CA07P-6L
TELMISARTAN ACTAVIS 80mgCOMPR.80 mgACTAVIS GROUP PTC EHF - ISLANDAC09CA07P-6L
TELMISARTAN HCT EGIS 40 mg/12,5 mgCOMPR.40mg/12,5mgEGIS PHARMACEUTICALS PLC - UNGARIAC09DA07P6L
TELMISARTAN HCT EGIS 80 mg/25 mgCOMPR.80mg/25mgEGIS PHARMACEUTICALS PLC - UNGARIAC09DA07P6L
TEZEO 40 mgCOMPR.40mgZENTIVA K.S. - REPUBLICA CEHAC09CA07P6L
TEZEO 80 mgCOMPR.80mgZENTIVA K.S. - REPUBLICA CEHAC09CA07P6L
TEZEO HCT 80 mg/12,5 mgCOMPR.80mg/12,5mgZENTIVA K.S. - REPUBLICA CEHAC09DA07P6L
TEZEO HCT 80 mg/25 mgCOMPR.80mg/25mgZENTIVA K.S. - REPUBLICA CEHAC09DA07P6L
TOLMIDUO 40 mg/1,5 mgCOMPR. ELIB. MODIF.40mg/1,5mgKRKA, D.D., NOVO MESTO - SLOVENIAC09DA07P6L
TOLMIDUO 80 mg/1,5 mgCOMPR. ELIB. MODIF.80mg/1,5mgKRKA, D.D., NOVO MESTO - SLOVENIAC09DA07P6L
TOLUCOMBI 80 mg/12,5mgCOMPR.80mg/12,5mgKRKA, D.D., NOVO MESTO - SLOVENIAC09DA07PRF
TOLUCOMBI 80 mg/25mgCOMPR.80mg/25mgKRKA D.D. - SLOVENIAC09DA07PRF
TOLURA 40 mgCOMPR.40mgKRKA, D.D., NOVO MESTO - SLOVENIAC09CA07P-6L
TOLURA 80 mgCOMPR.80mgKRKA, D.D., NOVO MESTO - SLOVENIAC09CA07P-6L
TWYNSTA 40 mg/10 mgCOMPR.40 mg/10 mgBOEHRINGER INGELHEIM INTERNATIONAL GMBH - GERMANIAC09DB04P-RF
TWYNSTA 40 mg/5 mgCOMPR.40 mg/5 mgBOEHRINGER INGELHEIM INTERNATIONAL GMBH - GERMANIAC09DB04P-RF
TWYNSTA 80 mg/10 mgCOMPR.80 mg/10 mgBOEHRINGER INGELHEIM INTERNATIONAL GMBH - GERMANIAC09DB04P-RF
TWYNSTA 80 mg/5 mgCOMPR.80 mg/5 mgBOEHRINGER INGELHEIM INTERNATIONAL GMBH - GERMANIAC09DB04P-RF
YLPIO 80 mg/2,5 mgCOMPR.80mg/2,5mgPRO. MED.CS PRAHA A.S. - REPUBLICA CEHAC09DA07P6L

Data extracted automatically from the documents published by CNAS (cnas.ro/protocoale-terapeutice) and from the ANMDM medicines register. For information only; the official text (the Ministry of Health / CNAS orders published in the Official Gazette) prevails. Protocol names and texts are shown in Romanian, as published.